Achieve Life Sciences, Inc. (ACHV) financial statements (2020 and earlier)

Company profile

Business Address 520 PIKE STREET
SEATTLE, WA 98101
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:715526554739
Cash and cash equivalents710515342815
Short-term investments 5 10211925
Other undisclosed cash, cash equivalents, and short-term investments (0) 000(0)
Restricted cash and investments  0  0 
Receivables 001069
Prepaid expense 10   6
Other current assets     0 
Other undisclosed current assets00 1220
Total current assets:816627575654
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000100
Intangible assets, net (including goodwill)334   
Goodwill111    
Intangible assets, net (excluding goodwill)223    
Restricted cash and investments00000 0
Other noncurrent assets0000001
Total noncurrent assets:4441112
TOTAL ASSETS:11191027585656
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22153214
Accounts payable1002100
Accrued liabilities01021112
Employee-related liabilities1100112
Debt0000001
Deferred revenue and credits  5  
Other undisclosed current liabilities111412200
Total current liabilities:3328212215
Noncurrent Liabilities
Long-term debt and lease obligation00 0004
Capital lease obligations0 0004
Operating lease, liability0
Total noncurrent liabilities:00 0004
Total liabilities:3329212218
Stockholders' equity
Stockholders' equity attributable to parent, including:816819373437
Common stock0000000
Additional paid in capital514121213212191168
Accumulated other comprehensive income0003333
Accumulated deficit(43)(25)(13)(197)(177)(160)(134)
Warrants and rights outstanding     30
Other undisclosed stockholders' equity attributable to parent     (3)(0)
Total stockholders' equity:816819373437
TOTAL LIABILITIES AND EQUITY:11191027585656

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues
(Revenue, Net)
   5   
Cost of revenue   (1)   
Gross profit:   4   
Operating expenses(17)(13)(7)(25)(37)(57)(65)
Operating loss:(17)(13)(7)(21)(37)(57)(65)
Nonoperating income (expense)00(7)1233
Investment income, nonoperating0010000
Other nonoperating income (expense)(0)(0)(0)(0)(0)(0)0
Loss from continuing operations before income taxes:(17)(13)(14)(20)(35)(54)(62)
Income tax benefit  3    
Loss before gain (loss) on sale of properties:(17)(13)(11)(20)(35)(54)(62)
Other undisclosed net income0      
Net loss:(17)(13)(11)(20)(35)(54)(62)
Other undisclosed net income attributable to parent    182730
Net loss available to common stockholders, diluted:(17)(13)(11)(20)(17)(26)(32)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(17)(13)(11)(20)(35)(54)(62)
Other comprehensive income (loss) (0) 00(0)0
Other undisclosed comprehensive loss(0)      
Comprehensive loss:(17)(13)(11)(20)(35)(54)(62)
Other undisclosed comprehensive income, net of tax, attributable to parent00  182730
Comprehensive loss, net of tax, attributable to parent:(17)(13)(11)(20)(17)(26)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: